National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

tetradecanoylphorbol acetate
A phorbol ester with potential antineoplastic effects. Tetradecanoylphorbol acetate (TPA) induces maturation and differentiation of hematopoietic cell lines, including leukemic cells. This agent may induce gene expression and protein kinase C (PKC) activity. In addition to potential antineoplastic effects, TPA may exhibit tumor promoting activity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Lonomycin
Phorbol Myristate Acetate
Abbreviations:PMA
TPA
Chemical structure name:12-O-tetradecanoylphorbol-13-acetate



Previous:tetanus toxoid, tetanus toxoid helper peptide, tetanus-CMV fusion peptide vaccine, tetracycline antibiotic, tetracycline hydrochloride
Next:tetrahydrouridine, tetrodotoxin, tezacitabine, TGF-beta-resistant LMP-specific cytotoxic T-lymphocytes, TGFa-PE38 immunotoxin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov